May 2024 – content

Life Sciences  

Cell culture media expert joins Ampersand’s portfolio

Acquisitions benefit Porvair’s Laboratory and Aerospace & Industrial divisions

Ampersand invests in cryo-EM services company

Antibody manufacturer sold to equity firm

Acquisition of digital microfluidics firm to solidify Integra Bio’s pandemic growth

BioLabs enters partnership with SPT Labtech


General Laboratory

Spectroscopy accessories pioneers combine with equity investment help

Indutrade buys two analytics-focussed companies

ARC sells exclusive rights to catalytic microreactor products

Anton Paar opens two more foreign subsidiaries

Excelitas moves headquarters


Process & hand-held instrumentation

Sartorius expands global manufacturing capacity

Sick and E+H to create JV targeting cleaner industries



Instrument sales up at Standard BioTools on eve of merger

Perfect mix of trends put Bio-Rad LS into tail spin

Demand reduction hits Sartorius after three years of growth

Porvair Laboratory sees organic sales reductions

Takara Bio hits the pandemic buffers

Chinese and pharma weakness forces Waters into decline              

Specac continues pandemic recovery with reduced growth rates

Beijing Labtech doubles R&D spend

Logistics delays strike Mettler-Toledo in the fourth quarter

Destocking causes blip in Trajan’s growth history

Elementar sees sharp drop of extra-EU sales in 2021

Acquisition helps Getinge LS to report growth in 2023

Sick misses 2023 growth target

OSI Systems growth powered by Security division

Process automation sole source of growth for E+H in 2023

Changes at Leidos may result in spot light on SES

Smiths Detection’s growth led by other security applications